SPOTLIGHT -
FDA Accepts NDA, Grants PDUFA Date for Investigational Schizophrenia Treatment
The FDA’s decision is set for September 2024.
Coupling Passion with Compassion in the Life of Rosalynn Carter and Ourselves
Rosalynn Carter’s life can serve as an example to us all.
Degrees of Revealedness
How does one heal? Perhaps by "degrees of revealedness," according to a psychiatrist's reflections.
Constipation Conundrum: A Case of Clozapine-Associated Pseudo-Obstruction and Ogilvie Syndrome
Examine this case in which a patient presents with extreme constipation.
Calendar Psychiatry and a Hoped for International Day of Thanksgiving
How do specific calendar days impact mental health?
Problem Gaming? Consider Dopamine Detoxification
Problematic gaming is often recognized in clinical practice, but can be challenging to treat. Here’s what you can do.
The Week in Review: November 20-24
From late-life treatment-resistant depression to the mental health benefits of gratitude, here are highlights from the week in Psychiatric Times.
Anxiety Research Roundup: November 24, 2023
What is new in research on anxiety symptoms and disorders?
What Are You Thankful for This Year?
Tell us what you're thankful for!
Celebrating Thanksgiving 2023
Psychiatric Times revisits some meaningful reflections on Thanksgiving, family traditions, and the value of gratitude and thankfulness.
Thanksgiving Tree
A psychiatrist reflects on gratitude and Thanksgiving...
It’s National Gratitude Month—in a World of Woe
In tough times, the cultivation of gratitude can help our patients—and us, too.
How Innovation Drives Access to Crisis Care in Rural Communities
Exploring new opportunities to offset the unique obstacles seen in rural communities.
Intimate Partner Violence Victimization: How It Relates to Substance Use in Women
In this CME, review the risks and clinical implications of intimate partner violence on women’s substance use and treatment.
Poetic Canvas
A psychiatrist reflects on how much we all have in common and the need for healing...
Anxiolytic Effects of Ketamine
Ketamine for anxiety? Researchers performed a systematic review and meta-analysis of ketamine’s anxiolytic effects.
The Gaza-Israel War: “A Major Poetic Emergency”
A poetic conversation among a Palestinian Israeli psychologist, an Italian Canadian psychiatrist, and a Canadian United Church Pastor in a time of war.
Late-Life Treatment-Resistant Depression
The Week in Review: November 13-17
From sleep disturbances in ADHD to psychotherapy for treatment-resistant depression, here are highlights from the week in Psychiatric Times.
Psychedelics Research Roundup: November 17, 2023
What is new in research on psychedelics?
Psychotherapy for Treatment-Resistant Depression Is Overlooked, Underused
"Evidence indicates that psychotherapy may yield greater durability of treatment gains than pharmacotherapy."
Are We All Subject to Some Psychological Hostage-Taking?
What are some examples of psychological hostage-taking?
Considerations for Transgender Patients
It is Transgender Awareness Week. Here’s what you need to know as a clinician.
The Importance of Refining the Depression Diagnosis
In this Special Report, let's re-evalute depression.
Changing the Way Climate Change Psychiatry Is Researched: A Medical Student Perspective
A recent study serves as a model for future studies and lists several implications for the future of climate change psychiatric research.
In Memoriam: For the Dead and the Living, A Delayed Eulogy for Eyad El-Sarraj, MD
Let us honor Eyad El-Sarraj, MD's vision together.
Your Medicare Patients Are Struggling
About 1 in 6 of Medicare patients report trouble paying Medicare bills and debt.
How JFK Killed My Father
"It was a time when men wore fedoras banded on the crown, each band with a feather tucked into a bow, and inside, sweat bands carved from calf skins with their sweet smell of animal and earth."
Examining Sex-Specific Associations Between Schizophrenia and Cannabis Use Disorder
Young men appear to be particularly susceptible to the effects of cannabis on schizophrenia.
Lifting the “Brain Fog” of Long COVID With TMS
TMS for the treatment of neuropsychiatric symptoms in patients with long COVID appeared to improve their cognitive function and symptoms of depression.